Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bioheart amends IPO

Bioheart (Sunrise, Fla.) raised the number of shares and lowered the proposed price range

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE